Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated 23 minutes ago
Kura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential
23 minutes ago
Kura Oncology has published early data on darlifarnib in combination with Bristol...
Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
about 2 hours ago
Eli Lilly has splashed up to $3.8 billion on an infectious disease...
Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
about 3 hours ago
Faced with a future of evaporating Xtandi sales, Astellas has set out...
Lilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitors
1 day ago
Eli Lilly is laying the groundwork for a phase 2 trial of...
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
4 days ago
Recorded at Fierce Biotech Week in Boston, this episode of “The Top...
Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both
4 days ago
It’s been more than four years since Novartis shook up the CAR-T...
OSE turns up the heat on ovarian cancer with phase 2, Keytruda-supported win
4 days ago
OSE Immunotherapeutics has shared phase 2 data on its neo-epitope vaccine candidate...
Biogen axes Denali-partnered Parkinson’s prospect after phase 2 flop
4 days ago
A phase 2b trial of Biogen and Denali Therapeutics’ Parkinson’s disease candidate...
Chutes & Ladders—Former FDA leader takes new biotech Turn
5 days ago
Stephen Hahn, M.D., who served as the commissioner of the FDA for...
ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
5 days ago
According to an abstract released ahead of the ASCO 2026 annual meeting...
Medtronic inks $650M deal for SPR Therapeutics
5 days ago
Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company...
Betting on biotech: Prediction markets set sights on clinical trials
5 days ago
Several biotech contracts are rotating through Kalshi and Polymarket, while a recently...